Literature DB >> 22307040

Trogocytosis of CD80 and CD86 by induced regulatory T cells.

Peng Gu1, Julia Fang Gao, Cheryl A D'Souza, Aleksandra Kowalczyk, Kuang-Yen Chou, Li Zhang.   

Abstract

Trogocytosis is a process which involves the transfer of membrane fragments and cell surface proteins between cells. Various types of T cells have been shown to be able to acquire membrane-bound proteins from antigen-presenting cells and their functions can be modulated following trogocytosis. However, it is not known whether induced regulatory T cells (iTregs) can undergo trogocytosis, and if so, what the functional consequences of this process might entail. In this study, we show that iTregs can be generated from CD80(-/-)CD86(-/-) double knockout (DKO) mice. Using flow cytometry and confocal fluorescence microscopy, we demonstrate that iTregs generated from DKO mice are able to acquire both CD80 and CD86 from mature dendritic cells (mDCs) and that the acquisition of CD86 occurs to a higher extent than that of CD80. Furthermore, we found that after co-incubation with iTregs, dendritic cells (DCs) downregulate their surface expression of CD80 and CD86. The trogocytosis of both CD80 and CD86 occurs in a cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), CD28 and programmed death ligand-1 (PDL1)-independent manner. Importantly, we showed that iTregs that acquired CD86 from mDCs expressed higher activation markers and their ability to suppress naive CD4(+) T-cell proliferation was enhanced, compared to iTregs that did not acquire CD86. These data demonstrate, for the first time, that iTregs can acquire CD80 and CD86 from mDCs, and the acquisition of CD86 may enhance their suppressive function. These findings provide novel understanding of the interaction between iTregs and DCs, suggesting that trogocytosis may play a significant role in iTreg-mediated immune suppression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307040      PMCID: PMC4002813          DOI: 10.1038/cmi.2011.62

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  39 in total

1.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.

Authors:  Z X Zhang; L Yang; K J Young; B DuTemple; L Zhang
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma.

Authors:  P Balbo; M Silvestri; G A Rossi; E Crimi; S E Burastero
Journal:  Clin Exp Allergy       Date:  2001-04       Impact factor: 5.018

3.  T cells acquire cell surface determinants of APC via in vivo trogocytosis during viral infections.

Authors:  Kerstin Rosenits; Selina J Keppler; Smiljka Vucikuja; Peter Aichele
Journal:  Eur J Immunol       Date:  2010-12       Impact factor: 5.532

4.  Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.

Authors:  Gang Zhou; Zhi-Chun Ding; Jie Fu; Hyam I Levitsky
Journal:  J Immunol       Date:  2011-01-17       Impact factor: 5.422

5.  Transfer of cell membrane components via trogocytosis occurs in CD4+ Foxp3+ CD25+ regulatory T-cell contact-dependent suppression.

Authors:  D Bahcheli; V Hay; J L Nadeau; C A Piccirillo
Journal:  Autoimmunity       Date:  2011-05-23       Impact factor: 2.815

6.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

7.  Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.

Authors:  J M Lumsden; J M Roberts; N L Harris; R J Peach; F Ronchese
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

8.  Acquisition of CD80 (B7-1) by T cells.

Authors:  H Sabzevari; J Kantor; A Jaigirdar; Y Tagaya; M Naramura; J Hodge; J Bernon; J Schlom
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

9.  T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells.

Authors:  I Hwang; J F Huang; H Kishimoto; A Brunmark; P A Peterson; M R Jackson; C D Surh; Z Cai; J Sprent
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

10.  Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

Authors:  T Takahashi; T Tagami; S Yamazaki; T Uede; J Shimizu; N Sakaguchi; T W Mak; S Sakaguchi
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  28 in total

1.  Trogocytosis-Mediated Intracellular Signaling in CD4+ T Cells Drives TH2-Associated Effector Cytokine Production and Differentiation.

Authors:  Jim Reed; Scott A Wetzel
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

Review 2.  Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses.

Authors:  Kerry L Hilligan; Franca Ronchese
Journal:  Cell Mol Immunol       Date:  2020-05-20       Impact factor: 11.530

Review 3.  Regulatory T cells as a new therapeutic target for atherosclerosis.

Authors:  Han-Xiao Ou; Bing-Bing Guo; Qi Liu; Yu-Kun Li; Zhen Yang; Wen-Jie Feng; Zhong-Cheng Mo
Journal:  Acta Pharmacol Sin       Date:  2018-01-11       Impact factor: 6.150

4.  Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+)CD25 (+)FOXP3 (+) regulatory T-cells and inhibiting macrophage foam cell formation.

Authors:  Zhi Xiao Wang; Chong Quan Wang; Xiao Yan Li; Gao Ke Feng; Hong Ling Zhu; Yan Ding; Xue Jun Jiang
Journal:  Mol Cell Biochem       Date:  2014-11-12       Impact factor: 3.396

Review 5.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma.

Authors:  Masaharu Kawashima; Joaquim Carreras; Hiroshi Higuchi; Ryutaro Kotaki; Takahiro Hoshina; Kazuki Okuyama; Naoto Suzuki; Masatoshi Kakizaki; Yuji Miyatake; Kiyoshi Ando; Masafumi Nakayama; Shinjiro Umezu; Ryouichi Horie; Yuriko Higuchi; Koko Katagiri; Susumu Goyama; Toshio Kitamura; Kenji Chamoto; Shingo Yano; Naoya Nakamura; Ai Kotani
Journal:  Leukemia       Date:  2020-02-24       Impact factor: 11.528

Review 7.  Regulatory cells and transplantation tolerance.

Authors:  Stephen P Cobbold; Herman Waldmann
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

Review 8.  The Role of Trogocytosis in the Modulation of Immune Cell Functions.

Authors:  Kensuke Miyake; Hajime Karasuyama
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

Review 9.  Shaping of T Cell Functions by Trogocytosis.

Authors:  Masafumi Nakayama; Arisa Hori; Saori Toyoura; Shin-Ichiro Yamaguchi
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

Review 10.  T Follicular Regulatory Cells: Choreographers of Productive Germinal Center Responses.

Authors:  Yisi Lu; Joe Craft
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.